Psychoanalytically oriented brief group treatment for borderline personality disorder: a randomised controlled trial

ISRCTN ISRCTN79187618
DOI https://doi.org/10.1186/ISRCTN79187618
Protocol serial number N0573173216
Sponsor Record Provided by the NHSTCT Register - 2007 Update - Department of Health
Funders Northumberland, Tyne and Wear NHS Foundation Trust, NHS R&D Support Funding
Submission date
28/09/2007
Registration date
28/09/2007
Last edited
10/07/2017
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Mental and Behavioural Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Ravi Lingam
Scientific

Regional Department of Psychotherapy
Claremont House
Off Framlington Place
Newcastle upon Tyne
NE2 4AA
United Kingdom

Phone +44 (0)191 2824547
Email Ravi.Lingam@nmht.nhs.uk

Study information

Primary study designInterventional
Study designRandomised controlled trial
Secondary study designRandomised controlled trial
Study type Participant information sheet
Scientific titlePsychoanalytically oriented brief group treatment for borderline personality disorder: a randomised controlled trial
Study objectivesIs psychoanalytically oriented brief group psychotherapy an effective treatment for borderline personality disorder?
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedMental and Behavioural Disorders: Borderline personality disorder
InterventionThe intervention to be researched is a Psychoanalytic Brief Group treatment, it is a 20-week outpatient programme. There are two treatment groups. Each group will consist of 8 subjects. The control will consist of a waiting list control. This will be treatment-as-usual for the subjects and will consist of their ongoing existing treatment in psychiatric or primary care services.
Intervention typeBehavioural
Primary outcome measure(s)Is a psychoanalytically-oriented brief group therapy an effective treatment for borderline personality disorder?
Key secondary outcome measure(s)Reduction in self harm and suicidal ideation, reduction in symptoms and improvement in function and the cost implication of this treatment
Completion date09/01/2008

Eligibility

Participant type(s)Patient
Age groupNot Specified
SexNot Specified
Target sample size at registration32
Key inclusion criteriaClinical diagnosis of Borderline Personality Disorder meeting DSM-IV criteria and clinical judgment of capacity of psychological mindedness
Key exclusion criteriaClinical risk assessment that there may be a significant acute risk of suicide or harm to others, that there is an active psychotic illness, or that there is use of alcohol or drugs to the extent that the subject cannot engage with the treatment.
Date of first enrolment09/01/2006
Date of final enrolment09/01/2008

Locations

Countries of recruitment

  • United Kingdom
  • England

Study participating centre

Regional Department of Psychotherapy
Newcastle upon Tyne
NE2 4AA
United Kingdom

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Participant information sheet Participant information sheet 11/11/2025 11/11/2025 No Yes

Editorial Notes

10/07/2017: No publications found, verifying study status with principal investigator.